Literature DB >> 12185203

Human kallikrein 10 expression in normal tissues by immunohistochemistry.

Constantina D Petraki1, Vassiliki N Karavana, Liu-Ying Luo, Eleftherios P Diamandis.   

Abstract

The normal epithelial cell-specific 1 (NES1) gene (official name kallikrein gene 10, KLK10) was recently cloned and encodes for a putative secreted serine protease (human kallikrein 10, hK10). Several studies have confirmed that hK10 shares many similarities with the other kallikrein members at the DNA, mRNA, and protein levels. The enzyme was found in biological fluids, tissue extracts, and serum. Here we report the first detailed immunohistochemical (IHC) localization of hK10 in normal human tissues. We used the streptavidin-biotin method with two hK10-specific antibodies, a polyclonal rabbit and a monoclonal mouse antibody, developed in house. We analyzed 184 paraffin blocks from archival, current, and autopsy material, prepared from almost every normal human tissue. The staining pattern, the distribution of the immunostaining, and its intensity were studied in detail. Previously, we reported the expression of another novel human kallikrein, hK6, by using similar techniques. The IHC expression of hK10 was generally cytoplasmic and not organ-specific. A variety of normal human tissues expressed the protein. Glandular epithelia constituted the main immunoexpression sites, with representative organs being the breast, prostate, kidney, epididymis, endometrium, fallopian tubes, gastrointestinal tract, bronchus, salivary glands, bile ducts, and gallbladder. The choroid plexus epithelium, the peripheral nerves, and some neuroendocrine organs (including the islets of Langerhans, cells of the adenohypophysis, the adrenal medulla, and Leydig cells) expressed the protein strongly and diffusely. The spermatic epithelium of the testis expressed the protein moderately. A characteristic immunostaining was observed in Hassall's corpuscles of the thymus, oxyphilic cells of the thyroid and parathyroid glands, and chondrocytes. Comparing these results with those of hK6, we observed that both kallikreins had a similar IHC expression pattern.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185203     DOI: 10.1177/002215540205000912

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.

Authors:  Maroulio Talieri; Dimitra K Alexopoulou; Andreas Scorilas; Dimitris Kypraios; Niki Arnogiannaki; Marina Devetzi; Matina Patsavela; Dimitris Xynopoulos
Journal:  Tumour Biol       Date:  2011-04-12

3.  Proteins secreted by embryonic stem cells activate cardiomyocytes through ligand binding pathways.

Authors:  W A LaFramboise; P Petrosko; J M Krill-Burger; D R Morris; A R McCoy; D Scalise; D E Malehorn; R D Guthrie; M J Becich; R Dhir
Journal:  J Proteomics       Date:  2010-01-04       Impact factor: 4.044

4.  Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.

Authors:  Xiaocong Geng; Yueyang Liu; Sandra Diersch; Matthias Kotzsch; Sabine Grill; Wilko Weichert; Marion Kiechle; Viktor Magdolen; Julia Dorn
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

5.  Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Authors:  Oliver Goldhardt; Inanna Warnhoff; Igor Yakushev; Ilijana Begcevic; Hans Förstl; Viktor Magdolen; Antoninus Soosaipillai; Eleftherios Diamandis; Panagiotis Alexopoulos; Timo Grimmer
Journal:  Transl Neurodegener       Date:  2019-08-27       Impact factor: 8.014

6.  Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.

Authors:  F Rückert; M Hennig; C D Petraki; D Wehrum; M Distler; A Denz; M Schröder; G Dawelbait; H Kalthoff; H-D Saeger; E P Diamandis; C Pilarsky; R Grützmann
Journal:  Br J Cancer       Date:  2008-10-14       Impact factor: 7.640

7.  NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.

Authors:  Jiajia Hu; Hu Lei; Xiaochun Fei; Sheng Liang; Hanzhang Xu; Dongjun Qin; Yue Wang; Yingli Wu; Biao Li
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

8.  Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10.

Authors:  Mekdes Debela; Viktor Magdolen; Wolfram Bode; Hans Brandstetter; Peter Goettig
Journal:  Biol Chem       Date:  2016-12-01       Impact factor: 3.915

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.